Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Proliferative Diabetic Retinopathy(NPDR)”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Early research (Phase 1)Study completedNCT06487845
What this trial is testing

Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Who this might be right for
Chronic Kidney DiseaseNon-proliferative Diabetic RetinopathyHealthy Volunteers
Bayer 24
Not applicableUnknownNCT04000789
What this trial is testing

The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)

Who this might be right for
Non-Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy New Vessels on DiscDry Eye Syndromes
Dr Cipto Mangunkusumo General Hospital 96
Testing effectiveness (Phase 2)Looking for participantsNCT07259928
What this trial is testing

Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion

Who this might be right for
Non-Proliferative Diabetic RetinopathyRetinal Vein Occlusion
Annexin Pharmaceuticals AB 12
Testing effectiveness (Phase 2)Study completedNCT05383209
What this trial is testing

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
EyePoint Pharmaceuticals, Inc. 77
Large-scale testing (Phase 3)Study completedNCT00131144
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 583
Not applicableNot Yet RecruitingNCT05852132
What this trial is testing

Clinical Study on Prognosis of Patients With Severe NPDR Undergoing Vitrectomy

Who this might be right for
Non Proliferative Diabetic Retinopathy(NPDR)
Fei Gao 249
Large-scale testing (Phase 3)Study completedNCT00130845
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 312
Large-scale testing (Phase 3)Ended earlyNCT05066230
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Non-proliferative Diabetic Retinopathy
Kodiak Sciences Inc 253
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236645
What this trial is testing

Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Not applicableUnknownNCT04103671
What this trial is testing

Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Non Proliferative Diabetic Retinopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University 272
Not applicableUnknownNCT03863535
What this trial is testing

PRP vs PRP+IVC for Severe nPDR

Who this might be right for
Severe Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus
Ruijin Hospital 40
Post-approval studies (Phase 4)Study completedNCT07230184
What this trial is testing

To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
AJU Pharm Co., Ltd. 53
Not applicableStudy completedNCT01145599
What this trial is testing

Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures

Who this might be right for
Type 2 DiabetesNon Proliferative Diabetic Retinopathy
European Vision Institute Clinical Research Network 374
Very early researchNot Yet RecruitingNCT07198815
What this trial is testing

A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)Diabetic Retinal MicroangiopathyRetinal Microaneurysms+1 more
Sichuan Academy of Medical Sciences 10
Not applicableUnknownNCT01759121
What this trial is testing

Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Severe Non-proliferative Diabetic Retinopathy
Sun Yat-sen University 84
Not applicableStudy completedNCT03696810
What this trial is testing

Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2

Who this might be right for
NPDR - Non Proliferative Diabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 141
Not applicableLooking for participantsNCT06713720
What this trial is testing

Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyNon-Proliferative Diabetic RetinopathyRemote Ischemic Conditioning+2 more
Xuxiang Zhang, MD 68
Testing effectiveness (Phase 2)Study completedNCT05681884
What this trial is testing

Safety and Efficacy of Faricimab in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Greater Houston Retina Research 179
Testing effectiveness (Phase 2)Looking for participantsNCT06770933
What this trial is testing

Evaluate the Efficacy and Safety of Orally Administered VX-01

Who this might be right for
Diabetic RetinopathyNPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd 100
Testing effectiveness (Phase 2)Ended earlyNCT02681809
What this trial is testing

Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR

Who this might be right for
Diabetic RetinopathyPosterior Vitreous DetachmentDisease Progression
ThromboGenics 48
Next Page